(2S,5S)-2,5-Dimethylmorpholine

Catalog No.: 
ACQVTZ514
CAS No.: 
1258277-12-1
Molecular Formula: 
C6H13NO
Molecular Weight: 
115.18
(2S,5S)-2,5-Dimethylmorpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$112.00In stockInquiry
250mg95%$223.00In stockInquiry
500mg95%$400.00In stockInquiry
1g95%$718.00In stockInquiry
5g95%$2870.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,5S)-2,5-Dimethylmorpholine
IUPAC Name(2S,5S)-2,5-dimethylmorpholine
MDL No.MFCD14586373
Molecular FormulaC6H13NO
Molecular Weight115.18
SMILESC[C@H]1CO[C@@H](C)CN1
InChI KeyRPSYMAMREDJAES-WDSKDSINSA-N
Synonym(2S,5S)-2,5-Dimethyl-morpholine HCl;110915;Morpholine, 2,5-dimethyl-, (2S,5S)-;(2S,5S)-2,5-dimethylmorpholine - [D82043]
CAS No.1258277-12-1
PubChem CID641781

Safety Data

Pictogram
CorrosiveFlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H226-H302-H314
Precautionary Statement(s)
P210-P233-P240-P241-P242-P243-P264-P270-P280-P301+P312+P330-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P370+P378-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACQVTZ514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNJAK964 route compound structure diagram
    ACNJAK9641821813-41-5In Stock
  2. Then
  3. ACQVTZ514 route product structure diagram
    ACQVTZ5141258277-12-1In Stock
Inquiry

2. ACQVTZ514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQVTZ514 route product structure diagram
    ACQVTZ5141258277-12-1In Stock
Inquiry

3. ACQVTZ514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQVTZ514 route product structure diagram
    ACQVTZ5141258277-12-1In Stock
Inquiry

Comments (0)